243 related articles for article (PubMed ID: 20631872)
21. Benderamide A, a Cyclic Depsipeptide from a Singapore Collection of Marine Cyanobacterium cf.
Ding CYG; Ong JFM; Goh HC; Coffill CR; Tan LT
Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373109
[TBL] [Abstract][Full Text] [Related]
22. The hoiamides, structurally intriguing neurotoxic lipopeptides from Papua New Guinea marine cyanobacteria.
Choi H; Pereira AR; Cao Z; Shuman CF; Engene N; Byrum T; Matainaho T; Murray TF; Mangoni A; Gerwick WH
J Nat Prod; 2010 Aug; 73(8):1411-21. PubMed ID: 20687534
[TBL] [Abstract][Full Text] [Related]
23. Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.
Matthew S; Ross C; Rocca JR; Paul VJ; Luesch H
J Nat Prod; 2007 Jan; 70(1):124-7. PubMed ID: 17253864
[TBL] [Abstract][Full Text] [Related]
24. Enzymatic Cross-Linking of Side Chains Generates a Modified Peptide with Four Hairpin-like Bicyclic Repeats.
Lee H; Park Y; Kim S
Biochemistry; 2017 Sep; 56(37):4927-4930. PubMed ID: 28841794
[TBL] [Abstract][Full Text] [Related]
25. Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
Milligan KE; Marquez BL; Williamson RT; Gerwick WH
J Nat Prod; 2000 Oct; 63(10):1440-3. PubMed ID: 11076574
[TBL] [Abstract][Full Text] [Related]
26. Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix species.
Sitachitta N; Williamson RT; Gerwick WH
J Nat Prod; 2000 Feb; 63(2):197-200. PubMed ID: 10691708
[TBL] [Abstract][Full Text] [Related]
27. Wewakamide A and guineamide G, cyclic depsipeptides from the marine cyanobacteria Lyngbya semiplena and Lyngbya majuscula.
Han B; Gross H; McPhail KL; Goeger D; Maier CS; Gerwick WH
J Microbiol Biotechnol; 2011 Sep; 21(9):930-6. PubMed ID: 21952369
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic halogenated macrolides and modified peptides from the apratoxin-producing marine cyanobacterium Lyngbya bouillonii from Guam.
Matthew S; Salvador LA; Schupp PJ; Paul VJ; Luesch H
J Nat Prod; 2010 Sep; 73(9):1544-52. PubMed ID: 20704304
[TBL] [Abstract][Full Text] [Related]
29. Studies toward the total synthesis of Itralamide B and biological evaluation of its structural analogs.
Wang X; Lv C; Feng J; Tang L; Wang Z; Liu Y; Meng Y; Ye T; Xu Z
Mar Drugs; 2015 Apr; 13(4):2085-104. PubMed ID: 25871289
[TBL] [Abstract][Full Text] [Related]
30. Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula.
Han B; Gross H; Goeger DE; Mooberry SL; Gerwick WH
J Nat Prod; 2006 Apr; 69(4):572-5. PubMed ID: 16643028
[TBL] [Abstract][Full Text] [Related]
31. Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam.
Chlipala GE; Pham HT; Nguyen VH; Krunic A; Shim SH; Soejarto DD; Orjala J
J Nat Prod; 2010 Apr; 73(4):784-7. PubMed ID: 20373744
[TBL] [Abstract][Full Text] [Related]
32. Natural antifoulants from the marine cyanobacterium Lyngbya majuscula.
Tan LT; Goh BP; Tripathi A; Lim MG; Dickinson GH; Lee SS; Teo SL
Biofouling; 2010 Aug; 26(6):685-95. PubMed ID: 20658384
[TBL] [Abstract][Full Text] [Related]
33. Isolation of homodolastatin 16, a new cyclic depsipeptide from a Kenyan collection of Lyngbya majuscula.
Davies-Coleman MT; Dzeha TM; Gray CA; Hess S; Pannell LK; Hendricks DT; Arendse CE
J Nat Prod; 2003 May; 66(5):712-5. PubMed ID: 12762816
[TBL] [Abstract][Full Text] [Related]
34. Cyanobacteria-derived peptide antibiotics discovered since 2000.
Xue Y; Zhao P; Quan C; Zhao Z; Gao W; Li J; Zu X; Fu D; Feng S; Bai X; Zuo Y; Li P
Peptides; 2018 Sep; 107():17-24. PubMed ID: 30077717
[TBL] [Abstract][Full Text] [Related]
35. Lyngbyatoxins B and C, two new irritants from Lyngbya majuscula.
Aimi N; Odaka H; Sakai S; Fujiki H; Suganuma M; Moore RE; Patterson GM
J Nat Prod; 1990; 53(6):1593-6. PubMed ID: 2128518
[No Abstract] [Full Text] [Related]
36. Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway.
Vestola J; Shishido TK; Jokela J; Fewer DP; Aitio O; Permi P; Wahlsten M; Wang H; Rouhiainen L; Sivonen K
Proc Natl Acad Sci U S A; 2014 May; 111(18):E1909-17. PubMed ID: 24742428
[TBL] [Abstract][Full Text] [Related]
37. Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens.
Thornburg CC; Cowley ES; Sikorska J; Shaala LA; Ishmael JE; Youssef DT; McPhail KL
J Nat Prod; 2013 Sep; 76(9):1781-8. PubMed ID: 24016099
[TBL] [Abstract][Full Text] [Related]
38. Screening of a Bacillus subtilis Strain Producing Multiple Types of Cyclic Lipopeptides and Evaluation of Their Surface-tension-lowering Activities.
Habe H; Taira T; Imura T
J Oleo Sci; 2017; 66(7):785-790. PubMed ID: 28674328
[TBL] [Abstract][Full Text] [Related]
39. Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.
Suarez-Jimenez GM; Burgos-Hernandez A; Ezquerra-Brauer JM
Mar Drugs; 2012 May; 10(5):963-986. PubMed ID: 22822350
[TBL] [Abstract][Full Text] [Related]
40. Ralstonins A and B, Lipopeptides with Chlamydospore-Inducing and Phytotoxic Activities from the Plant Pathogen Ralstonia solanacearum.
Murai Y; Mori S; Konno H; Hikichi Y; Kai K
Org Lett; 2017 Aug; 19(16):4175-4178. PubMed ID: 28753290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
